Deutsche Bank Ag\ Clovis Oncology, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.63 - $2.96 $40,620 - $190,851	-64,477 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.43 - $3.14 $10,401 - $22,840	-7,274 Reduced 10.14%	64,477 $131,000
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $9,787 - $17,255	3,625 Added 5.32%	71,751 $195,000
Q3 2021 Nov 04, 2021	SELL	$4.06 - $5.8 $581,952 - $831,360	-143,338 Reduced 67.78%	68,126 $303,000
Q2 2021 Aug 11, 2021	BUY	$5.02 - $7.05 $674,677 - $947,505	134,398 Added 174.39%	211,464 $1.23 Million
Q1 2021 May 13, 2021	BUY	$4.81 - $10.34 $75,242 - $161,748	15,643 Added 25.47%	77,066 $541,000
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $68,586 - $106,450	16,607 Added 37.06%	61,423 $295,000
Q3 2020 Nov 12, 2020	SELL	$4.82 - $7.72 $2,853 - $4,570	-592 Reduced 1.3%	44,816 $261,000
Q2 2020 Aug 13, 2020	SELL	$5.69 - $9.69 $1.69 Million - $2.88 Million	-297,587 Reduced 86.76%	45,408 $306,000
Q1 2020 May 14, 2020	BUY	$3.77 - $11.0 $507,758 - $1.48 Million	134,684 Added 64.66%	342,995 $2.18 Million
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $691,116 - $3.79 Million	-230,372 Reduced 52.51%	208,311 $2.17 Million
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $352,976 - $1.38 Million	89,816 Added 25.75%	438,683 $1.72 Million
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $1.35 Million - $2.7 Million	105,045 Added 43.08%	348,867 $5.19 Million
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $4.49 Million - $7.71 Million	-254,469 Reduced 51.07%	243,822 $6.05 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $911,024 - $2.56 Million	78,334 Added 18.65%	498,291 $8.95 Million
Q3 2018 Dec 21, 2021	BUY	$29.37 - $49.48 $6.12 Million - $10.3 Million	208,237 Added 98.35%	419,957 $12.3 Million
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $1.16 Million - $1.95 Million	-39,474 Reduced 15.71%	211,720 $6.22 Million
Q2 2018 Apr 21, 2020	BUY	$42.06 - $62.4 $2.98 Million - $4.43 Million	70,937 Added 39.35%	251,194 $11.4 Million
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $13 Million - $19.3 Million	-309,501 Reduced 63.19%	180,257 $8.19 Million
Q1 2018 Oct 18, 2019	BUY	$50.12 - $67.72 $4.48 Million - $6.05 Million	89,348 Added 22.31%	489,758 $25.9 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $7.86 Million - $10.6 Million	156,782 Added 64.35%	400,410 $21.1 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $1.15 Million - $1.69 Million	19,990 Added 8.94%	243,628 $16.6 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $15 Million - $19 Million	223,638	223,638 $18.4 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account